Association of FEF<inf>25%–75%</inf> and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthma

Watcharoot KanchongkittiphonJonathan M. GaffinLianne KopelCarter R. PettyMary E. BollingerRachel L. MillerMatthew PerzanowskiElizabeth C. MatsuiWanda PhipatanakulChildren's Hospital of MichiganMahidol UniversityChildren's Hospital BostonHarvard Medical SchoolCentre universitaire de santé McGill, Hôpital de Montreal Pour EnfantsUniversity of Maryland School of MedicineColumbia University Medical CenterThe Johns Hopkins School of Medicine2018-12-112019-03-142018-12-112019-03-142016-07-01Annals of Allergy, Asthma and Immunology. Vol.117, No.1 (2016), 97-9915344436108112062-s2.0-84970002317https://repository.li.mahidol.ac.th/handle/20.500.14594/40795Mahidol UniversityImmunology and MicrobiologyAssociation of FEF<inf>25%–75%</inf> and bronchodilator reversibility with asthma control and asthma morbidity in inner-city children with asthmaArticleSCOPUS10.1016/j.anai.2016.04.029